Individual component completion versus bundle completion percentages
| Baseline (n=67) | Post phlebotomy (n=64) | Post 12-month outreach (n=62) | |
| Total DTaP | 90% | 94% | 90% |
| Total Hepb | 88% | 91% | 90% |
| Total Hib | 90% | 94% | 90% |
| Total IPV | 91% | 92% | 87% |
| Total Rotarix | 78% | 84% | 82% |
| Total PCV13 | 88% | 91% | 90% |
| Total MMR | 48% | 42% | 87% |
| Total VZV | 45% | 42% | 87% |
| Influenza | 88% | 91% | 94% |
| Newborn Summary | 67% | 83% | 84% |
| Pre-visit Questionnaire | 88% | 95% | 97% |
| PEDS Screen | 78% | 97% | 95% |
| Pb Screen | 57% | 78% | 85% |
| Bundle Completion | 57% | 58% | 80% |
*All measurement includes 3-month interval averages following launch of the quality improvement initiative (baseline) or intervention (post phlebotomy and post 12-month outreach).
DTaP, diphtheria, tetanus and acellular pertussis; Hepb, hepatitis B; Hib, haemophilus influenza; IPV, inactivated polio vaccines; MMR, measles, mumps and rubella; PCV, pneumococcal vaccines; VZV, varicella.